HPV Message Testing and Social Media Campaign

• ClinicalTrials.gov Identifier: NCT03747302
• Recruitment Status: Completed
• First Posted: November 20, 2018
• Last Update Posted: March 13, 2020
• Sponsor: Dartmouth-Hitchcock Medical Center
• Collaborators: National Cancer Institute (NCI); Norris Cotton Cancer Center
• Information provided by (Responsible Party): Ardis Olson, MD, Trustees of Dartmouth College

Tracking Information

• First Submitted Date: November 16, 2018
• First Posted Date: November 20, 2018
• Last Update Posted Date: March 13, 2020
• Actual Study Start Date: December 12, 2018
• Actual Primary Completion Date: September 9, 2019 (Final data collection date for primary outcome measure)

Current Primary Outcome Measures (submitted: November 16, 2018)

Changes in intention to vaccinate their child with HPV vaccine [ Time Frame: pre test immediately before viewing message and post test immediately after viewing message. Approximately one hour. ]

Pre and Post surveys of participants viewing a specific social message

• Original Primary Outcome Measures: Same as current
• Current Secondary Outcome Measures: Not Provided
• Original Secondary Outcome Measures: Not Provided
• Current Other Pre-specified Outcome Measures: Not Provided
• Original Other Pre-specified Outcome Measures: Not Provided

Descriptive Information

• Brief Title: HPV Message Testing and Social Media Campaign
• Official Title: HPV Message Testing and Social Media Campaign
• Brief Summary: This project involves a social media campaign to increase parent's knowledge and acceptance of the HPV (human papillomavirus) vaccine. The current vaccine protects against nine types of HPV, including seven that are known to cause cancer. The Centers for Disease Control and Prevention (CDC) estimates that the current HPV vaccine could prevent 90% of cancer cases caused by HPV, including cases of cervical cancer, oropharyngeal (mouth and throat) cancer, anal cancer, and others. About 150 and 104 cases of HPV-associated cancers are diagnosed each year in New Hampshire and Vermont, respectively-many of which could be prevented through vaccination. Currently, only 49.8% of New Hampshire adolescents and 44.3% of Vermont adolescents were not up-to-date for HPV vaccination as of 2016. This social media campaign is testing a set of campaign messages with parents locally and nationally to see which messages are most effective in improving their knowledge and acceptance of the vaccine. A study survey link will monitor the number of people reached and will measure parental intention to get their children vaccinated against HPV.
• Detailed Description: Not Provided
• Study Type: Interventional
• Study Phase: Not Applicable

Study Design

Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Masking Description:

Participants are not aware of which arm of social messaging they are receiving and whether they are receiving the control message or not

Primary Purpose: Health Services Research

Condition

• Vaccine
• Human Papilloma Virus

Intervention

• Other: Social Media Message about HPV and HPV vaccine
  Messages educate parents with facts about HPV vaccination.
• Other: Social media message about risk of electronic cigarettes.
  Messages educate parents with facts about electronic cigarettes. This is an attention control group without outcomes obtained.

Study Arms

• Experimental: HPV Messaging
  Subjects are randomized to receive one of five messages on one of the four themes about HPV vaccination.
  Intervention: Other: Social Media Message about HPV and HPV vaccine
• Control Message
  Subjects are randomized to receive one of five messages about electronic cigarettes.
  Intervention: Other: Social media message about risk of electronic cigarettes.

• Publications *: Not Provided

Recruitment Information

• Recruitment Status: Completed
• Actual Enrollment (submitted: March 11, 2020): 1096
• Original Estimated Enrollment (submitted: November 16, 2018): 1200
• Actual Study Completion Date: September 9, 2019
• Actual Primary Completion Date: September 9, 2019 (Final data collection date for primary outcome measure)

Eligibility Criteria

Inclusion Criteria:

• parents of children 9-14 years old

Exclusion Criteria:

• non-parents

Sex/Gender

• Sexes Eligible for Study: All

• Ages: Child, Adult, Older Adult
• Accepts Healthy Volunteers: Yes
• Contacts: Contact information is only displayed when the study is recruiting subjects
• Listed Location Countries: United States

Administrative Information

• NCT Number: NCT03747302
• Other Study ID Numbers: D18180; 3P30CA023108-38S4 ( U.S. NIH Grant/Contract )
• Has Data Monitoring Committee: No

U.S. FDA-regulated Product

• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No

• IPD Sharing Statement: Not Provided
• Responsible Party: Ardis Olson, MD, Trustees of Dartmouth College
• Study Sponsor: Dartmouth-Hitchcock Medical Center

Collaborators

• National Cancer Institute (NCI)
• Norris Cotton Cancer Center

Investigators

• Principal Investigator: Ardis L Olson, MD; Trustees of Dartmouth College
• Principal Investigator: Sun Jung Kim, PhD; Massey Cancer Center

• PRS Account: Dartmouth-Hitchcock Medical Center
• Verification Date: March 2020